Target intelligence / Profile preview

Catechin

Molecular classification
Other (Flavonoid/Polyphenol/Small molecule)
01

Overview

Catechins are polyphenolic flavonoids widely present in tea leaves, cocoa beans, red wine, berries, and some fruits. The most common forms are (+)-catechin and (-)-epicatechin. They possess two benzene rings connected by a dihydropyran ring with multiple hydroxyl groups that confer their chemical reactivity. Catechins exhibit significant antioxidant properties both by directly scavenging free radicals/reactive oxygen species and by modulating cellular defense mechanisms against oxidative damage through regulation of key enzymes and signaling pathways such as Nrf2/ARE. These actions contribute to their proposed health benefits including cardiovascular protection, anti-inflammatory effects, potential cancer prevention roles, neuroprotection via reduction of oxidative stress-related damage. However, their clinical utility is limited by low oral bioavailability in humans; further research into delivery methods or synergistic combinations may improve therapeutic outcomes. Importantly—"catechin antioxidant activity" should be understood as an attribute/function rather than a discrete druggable biological target.

Other names
(+)-catechin(-)-catechinepicatechinl-catechol
02

Mechanism of action

Scavenging reactive oxygen species directly. Inducing endogenous antioxidant pathways such as Keap1/Nrf2/ARE signaling. Inhibiting prooxidative enzymes like NADPH oxidase and COX2. Modulating transcription factors including NF-kB and AP-1 to reduce inflammation and oxidative stress. Enhancing levels of endogenous antioxidants like glutathione peroxidase and superoxide dismutase.

03

Biological functions

Antioxidant activityFree radical scavengingModulation of enzyme activities involved in oxidative stress response
04

Disease associations

Cardiovascular disease (protective role)Cancer (potential protective role)InflammationNeurodegenerative disease (potential protective effects inferred from antioxidant action)
05

Safety considerations

Low bioavailability in humans limits efficacy.Possible prooxidative effects at high concentrations or under certain conditions.Uncertain safety profile for long-term/high-dose supplementation due to possible toxicity from metabolites.
06

Biomarkers

Biomarkers of oxidative stress reduction in plasma after catechin consumption have been studied but no specific clinical biomarker for patient selection established yet.Potential markers include reduced lipid peroxidation products and improved endothelial function.

Beyond the preview

Go deeper on Catechin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Catechin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call